Article Details

JW Therapeutics Presents Latest Data of Carteyva® at 2022 ASCO Annual Meeting

Retrieved on: 2022-06-05 12:11:48

Tags for this article:

Click the tags to see associated articles and topics

JW Therapeutics Presents Latest Data of Carteyva® at 2022 ASCO Annual Meeting. View article details on hiswai:

Excerpt

PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up